Aquestive Therapeutics, Inc. — Form 10-Q
Filed August 11, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 28/100
What the filing says
Aquestive executed a 10-year lease for 19,345 sq ft at 184 Liberty Corner Road, Warren, NJ at $28.50–$33.00/sq ft annually ($551k–$638k/year), with security deposit of $137,833 and $967,250 tenant improvement allowance. Separately, Aquestive amended its Pharmanovia product distribution agreement (effective April 20, 2026) to permit subcontractor use, adjust pricing mechanics (profit-share option if direct-sales profit falls below threshold after specified date), and expand trademark filing scope to additional territories, with minimum volume commitments by geography and year.
Why this rating
Lease is ordinary facility cost (~$638k/yr ÷ $291.6M ≈ 0.22% of market cap annually). Pharmanovia amendment clarifies distribution mechanics but dollar impacts remain redacted ([****]). Both are routine operational/administrative events.
See more from August 11, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.